MedPath

Investigation of systemic microvascular dysfunction in heart failure with preserved ejection fraction in males and females

Not Applicable
Completed
Conditions
<p>Heart Failure with preserved Ejection Fraction (HFpEF)</p>
10019280
Registration Number
NL-OMON23162
Lead Sponsor
Academisch ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
1850
Inclusion Criteria

|
Patiënten met HFpEF: |

Exclusion Criteria

|
Exclusiecriteria voor deelname bij patiënten met HFpEF: |

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br><tr><br><td>The primary endpoint of this study is the difference in peripheral microvascular function assessed by flicker-light-induced retinal arteriolar microvascular %-dilation (retinal arteriolar dilation) in patients with HFpEF compared to control individuals, corrected for the most important confounders of microvascular function and HFpEF.</td><br></tr><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath